Medicare Compliance & Reimbursement
FEDS SEEK INFO ON BRISTOL-MYERS COMPLIANCE REVIEW
Internal review covers sales, marketing and pricing practices. In the latest development, New York-based Bristol-Myers Squibb Co. says the U.S. attorney's office in Massachusetts - a particularly aggressive office when it comes to health care fraud enforcement - wants the results of an internal compliance review the company is conducting of its sales and marketing practices. In an Aug. 8 filing with the Securities and Exchange Commission, the company notes that its review is designed to assess how well its practices comport with the anti-kickback statute. The review includes such hot-button compliance issues as Medicaid best-price requirements, drug pricing and Medicaid rebates. Shortly after discussing it with the U.S. attorney's office in Massachusetts, Bristol-Myers received a subpoena relating to the review, the company says in the SEC filing. Lesson Learned: Drugmakers should expect continued aggressive scrutiny on a series of key compliance issues, including kickbacks, average wholesale price issues, Medicaid rebates and best-price requirements.
As government scrutiny builds on pharma companies' sales and marketing practices, drugmakers are facing investigations from every quarter: the Department of Justice, state attorneys general, the HHS Office of Inspector General and even Congress.
Medicare Compliance & Reimbursement
- TENET FACES MORE SCRUTINY OF PHYSICIAN RELATIONSHIPS
This time, state fraud fighters in Florida are investigating the hospital chain.
Fraud fighters are paying [...] - MEDICARE PAY CUT LOOMING IN 2004
Only a few months after Congress turned a looming 4.4 percent Medicare pay cut into [...] - Dozens of Physician Procedures Slashed in 2004 Fee Schedule
99311, 45385, 99348 among hardest hit.
Physicians who see lots of patients in the nursing home [...] - ELECTRONIC CLAIMS EXCEPTIONS FEW AND FAR BETWEEN
Providers should get ready to go electronic with their Medicare claims.
When the Health Insurance Portability [...] - Top 4 Bases for Liability Under the False claims act
Learn these federal no-nos and prevent unwitting fraud.
When the government cracks down on False Claims [...] - EVERYONE DISLIKES AWP, BUTDOCS DISLIKE PROPOSED FIXES
Medicare beneficiaries and the government could save up to $45.2 billion over ten years if [...] - CMS SEEKS COMMENT ON FOUR PAYMENT SCHEMES
According to the Centers for Medicare & Medicaid Services, increasing practice expense reimbursements is irrevocably [...] - THREE-DAY INPATIENT STAY RULE VEXES SNFs, FEDS
The OIG thinks nursing homes are bungling hospital stay data
Skilled nursing facilities whose staffers don't [...] - Medicaid Probe Drives Supplier Out Of Business
DME suppliers should repeat this mantra: documentation, documentation, documentation.
A recent investigation focusing on three compliance [...] - HEALTH CARE EXECS BEWARE
Post-Enron hostility to corporate fraud takes its toll on a lab exec.
The growing disgust with [...] - FEDS SEEK INFO ON BRISTOL-MYERS COMPLIANCE REVIEW
Internal review covers sales, marketing and pricing practices.
As government scrutiny builds on pharma companies' sales [...] - ONLINE MEDICARE RESOURCES GET A LITTLE LESS COMPLICATED
CMS unsnarls a tangled web.
Confused by the sometimes-labyrinthine experience of navigating the Centers for Medicare [...] - M+C benes Spending More, But FFS Benes Spending even More
The average Medicare+Choice enrollee is spending about $1,964 out-of-pocket this year, 10 percent more than [...] - PROGRAM MEMO ROUNDUP
The interest rate for Medicare overpayments and underpayments went up August 11, rising from 11.625 [...]
